THQ
Get informed when a big investor buys or sells
+ FollowOvervalued by 182.4% based on the discounted cash flow analysis.
| Market cap | $773.64 Million |
|---|---|
| Enterprise Value | $998.64 Million |
| Dividend Yield | $2.16 (11.57%) |
| Earnings per Share | $-2.78 |
| Beta | 0.9 |
| Outstanding Shares | 41,379,167 |
| P/E Ratio | -6.73 |
|---|---|
| PEG | 3.71 |
| Price to Sales | -17.75 |
| Price to Book Ratio | 1.04 |
| Enterprise Value to Revenue | -28.84 |
| Enterprise Value to EBIT | 11.13 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.3 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 18.83%▲ 0.41% |
|---|---|
| Total Invested | $130.92M▼ 10.20% |
| Investors Holding | 87▼ 5.00% |
No data
Tekla Healthcare Opportunities Fund is a closed-end fund that invests in companies in the healthcare industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.